NDC 0179-0142

Lialda

Mesalamine

Lialda is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Kaiser Foundation Hospita. The primary component is Mesalamine.

• Product ID: 0179-0142_7bc2147d-1c6b-5a72-e053-2a91aa0a8140
• NDC: 0179-0142
• Product Type: Human Prescription Drug
• Proprietary Name: Lialda
• Generic Name: Mesalamine
• Dosage Form: Tablet, Delayed Release
• Route of Administration: ORAL
• Marketing Start Date: 2013-12-06
• Marketing End Date: 2019-03-31
• Marketing Category: NDA /
• Application Number: NDA022000
• Labeler Name: KAISER FOUNDATION HOSPITA
• Substance Name: MESALAMINE
• Active Ingredient Strength: 1 g/1
• Pharm Classes: Aminosalicylate
• NDC Exclude Flag: N

Packaging

NDC SPL Data Element Entries

NDC 0179-0142-70 [00179014270]

Lialda TABLET, DELAYED RELEASE

• Marketing Category: NDA
• Application Number: NDA022000
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2013-12-06
• Marketing End Date: 2019-03-31

Drug Details

NDC Crossover Matching brand name "Lialda" or generic name "Mesalamine"

NDC	Brand Name	Generic Name
0179-0142	Lialda	mesalamine
54092-476	Lialda	Lialda
0023-5901	Asacol HD	mesalamine
0430-0783	ASACOL HD	mesalamine
0023-5853	Delzicol	mesalamine
0093-5907	Mesalamine	Mesalamine
0093-9224	mesalamine	mesalamine
0378-1375	Mesalamine	mesalamine
0378-9230	Mesalamine	mesalamine
0472-1915	Mesalamine	Mesalamine
0037-0066	Rowasa	mesalamine
0037-0022	sfRowasa	mesalamine